We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Consort Medical Plc | LSE:CSRT | London | Ordinary Share | GB0000946276 | ORD 10P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 1,010.00 | 1,005.00 | 1,010.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMCSRT
RNS Number : 7668I
Consort Medical PLC
21 June 2017
21 June 2017
Consort Medical plc
Notification of Transactions of Directors or
Persons Discharging Managerial Responsibility and Connected Persons
On 20 June 2017 pursuant to the rules of the Consort Medical plc Performance Share Plan the following Directors/persons discharging managerial responsibilities ("PDMRs") of Consort Medical plc (the "Company"), were granted awards over ordinary shares at a share price of GBP10.67 ("Shares") in the Company as detailed against their name below:
Performance Share Plan Award
Hot Features
Premium
Director/PDMR Number of
Shares
------------------ ----------
Jon Glenn 45,385
------------------ ----------
Paul Hayes 29,990
------------------ ----------
Keyvan Djamarani 16,869
------------------ ----------
Manja Boerman 16,869
------------------ ----------
Each award was granted as a nil cost option.
Enquiries: Michelle Palmer Assistant Company Secertary 01442 867920
Consort Medical plc is a leading, global, single source pharma services drug and delivery device company. We are at the leading edge of innovation and we are committed to investing in patient, clinician and customer driven innovation to create new treatments, new markets and new opportunities.
Our businesses
Bespak is a global market leader in the manufacture of drug delivery devices for pharmaceutical partner companies, including respiratory, nasal, injectables and ocular products, and the manufacture of devices for the point of care diagnostics market. www.bespak.com.
Aesica is a leading provider of finished dose and active pharmaceutical ingredient (API) development and manufacturing services to pharmaceutical partners. www.aesica-pharma.com.
We employ more than 2000 people globally of which 1400 are located in the UK. We have UK facilities in King's Lynn, Cambridge, Nelson, Milton Keynes, Cramlington, Queenborough and Hemel Hempstead, German facilities in Monheim and Zwickau and a facility in Pianezza, Italy. Consort Medical is a public company quoted on the premium list of the London Stock Exchange (LSE: CSRT). www.consortmedical.com
1 Details of the person discharging managerial
responsibilities / person closely associated
---- ----------------------------------------------------------------------
a) Name Jonathan Glenn
---- ------------------------------ --------------------------------------
2 Reason for the notification
---- ----------------------------------------------------------------------
a) Position/status CEO
---- ------------------------------ --------------------------------------
b) Initial notification Initial notification
/Amendment
---- ------------------------------ --------------------------------------
3 Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
---- ----------------------------------------------------------------------
a) Name Consort Medical plc
---- ------------------------------ --------------------------------------
b) LEI 2138001TBP74FD66QT38
---- ------------------------------ --------------------------------------
4 Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
---- ----------------------------------------------------------------------
a) Description of Ordinary 10p shares
the financial
instrument, type
of instrument
----
Identification ISIN: GB0000946276
code
b) Nature of the Grant of ordinary shares
transaction pursuant to the Consort Medical
Performance Share Plan
---- ------------------------------ --------------------------------------
c) Price(s) and volume(s)
---- ---------------- -----------------
Price(s) Volume(s)
---- ---------------- -----------------
0 45,385
---------------- -----------------
d) Aggregated information n/a single transaction
----
- Aggregated volume
- Price
e) Date of the transaction 20 June 2017
---- ------------------------------ --------------------------------------
f) Place of the transaction Off market transaction
---- ------------------------------ --------------------------------------
1 Details of the person discharging managerial
responsibilities / person closely associated
---- ----------------------------------------------------------------------
a) Name Paul Hayes
---- ------------------------------ --------------------------------------
2 Reason for the notification
---- ----------------------------------------------------------------------
a) Position/status CFO
---- ------------------------------ --------------------------------------
b) Initial notification Initial notification
/Amendment
---- ------------------------------ --------------------------------------
3 Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
---- ----------------------------------------------------------------------
a) Name Consort Medical plc
---- ------------------------------ --------------------------------------
b) LEI 2138001TBP74FD66QT38
---- ------------------------------ --------------------------------------
4 Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
---- ----------------------------------------------------------------------
a) Description of Ordinary 10p shares
the financial
instrument, type
of instrument
----
Identification ISIN: GB0000946276
code
b) Nature of the Grant of ordinary shares
transaction pursuant to the Consort Medical
Performance Share Plan
---- ------------------------------ --------------------------------------
c) Price(s) and volume(s)
---- ---------------- -----------------
Price(s) Volume(s)
---- ---------------- -----------------
0 29,990
---------------- -----------------
d) Aggregated information n/a single transaction
----
- Aggregated volume
- Price
e) Date of the transaction 20 June 2017
---- ------------------------------ --------------------------------------
f) Place of the transaction Off market transaction
---- ------------------------------ --------------------------------------
1 Details of the person discharging managerial
responsibilities / person closely associated
---- ----------------------------------------------------------------------
a) Name Keyvan Djamarani
---- ------------------------------ --------------------------------------
2 Reason for the notification
---- ----------------------------------------------------------------------
a) Position/status Managing Director Bespak
Division
---- ------------------------------ --------------------------------------
b) Initial notification Initial notification
/Amendment
---- ------------------------------ --------------------------------------
3 Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
---- ----------------------------------------------------------------------
a) Name Consort Medical plc
---- ------------------------------ --------------------------------------
b) LEI 2138001TBP74FD66QT38
---- ------------------------------ --------------------------------------
4 Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
---- ----------------------------------------------------------------------
a) Description of Ordinary 10p shares
the financial
instrument, type
of instrument
----
Identification ISIN: GB0000946276
code
b) Nature of the Grant of ordinary shares
transaction pursuant to the Consort Medical
Performance Share Plan
---- ------------------------------ --------------------------------------
c) Price(s) and volume(s)
---- ---------------- -----------------
Price(s) Volume(s)
---- ---------------- -----------------
0 16,869
---------------- -----------------
d) Aggregated information n/a single transaction
----
- Aggregated volume
- Price
e) Date of the transaction 20 June 2017
---- ------------------------------ --------------------------------------
f) Place of the transaction Off market transaction
---- ------------------------------ --------------------------------------
1 Details of the person discharging managerial
responsibilities / person closely associated
---- ----------------------------------------------------------------------
a) Name Manja Boerman
---- ------------------------------ --------------------------------------
2 Reason for the notification
---- ----------------------------------------------------------------------
a) Position/status Manging Director Aesica Division
---- ------------------------------ --------------------------------------
b) Initial notification Initial notification
/Amendment
---- ------------------------------ --------------------------------------
3 Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
---- ----------------------------------------------------------------------
a) Name Consort Medical plc
---- ------------------------------ --------------------------------------
b) LEI 2138001TBP74FD66QT38
---- ------------------------------ --------------------------------------
4 Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
---- ----------------------------------------------------------------------
a) Description of Ordinary 10p shares
the financial
instrument, type
of instrument
----
Identification ISIN: GB0000946276
code
b) Nature of the Grant of ordinary shares
transaction pursuant to the Consort Medical
Performance Share Plan
---- ------------------------------ --------------------------------------
c) Price(s) and volume(s)
---- ---------------- -----------------
Price(s) Volume(s)
---- ---------------- -----------------
0 16,869
---------------- -----------------
d) Aggregated information n/a single transaction
----
- Aggregated volume
- Price
e) Date of the transaction 20 June 2017
---- ------------------------------ --------------------------------------
f) Place of the transaction Off market transaction
---- ------------------------------ --------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHFFLFLDQFBBBD
(END) Dow Jones Newswires
June 21, 2017 07:09 ET (11:09 GMT)
1 Year Consort Medical Chart |
1 Month Consort Medical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
